Skip to content

Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation in the Breast Oncologic Surgery

Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation (Virtual Reality) in the Breast Oncologic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03330717
Acronym
OncoHypnose
Enrollment
284
Registered
2017-11-06
Start date
2017-11-15
Completion date
2019-12-31
Last updated
2021-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasm

Brief summary

The aims of the study are to compare the recovering period between a group of patients with conventional sedation, a group using hypnosis as sedation during the surgery and a third group using hypnosis as a relaxation method and preparation but enjoying a classic sedation for their surgery. Comparaison of pain ( different types of pain), consumption of pain killers ,anxiety and fatigue on day0,1, 8 after surgery and every. 3 months during the first 2 years of follow up. Comparisons are also performed in substudies defined by treatments modalités. Inflammatory parameters s ( CRP\_ C reactive protein, NLR- ( neutrophils to lymphocyte ratio) are measured on Day 0, 1, 8 and also salivary Immunoglobulins and different endocannabinoids.

Detailed description

Hypnosis has already demonstrated benefits among breast cancer patients undergoing oncologic surgery. Different side effects were measured during the post operative period and at each follow up visit by physicians in order to carefully compare side effects in the 3 armes of patients.. Our hypothesis was that hypnosis sedation generates less perioperative inflammatory reaction. A substudy of 50 patients was also dedicated to the investigation ofsalivary immunoglobulins and dosage of differents endocannabinoids

Interventions

PROCEDUREGeneral anesthesia

Patients will undergo oncologic breast surgery on general anesthesia.

PROCEDUREHypnosis sedation

Patients will undergo oncologic breast surgery on hypnosis sedation.

PROCEDUREGeneral anesthesia with preoperative session of hypnosis

Patients will undergo surgery on general anesthesia but will have a preoperative session of hypnosis relaxation.

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patient over 18 years old * Signed informed consent form * Patient has to be in possession of her administrative laws and affiliated to the social security insurance. * The patient must have a diagnosis of resectable breast cancer (in situ or invasive breast cancer). . Surgical procedure must include evaluation of the axillary area (sentinel lymph node biopsy and or axillary dissection)

Exclusion criteria

* Patient under 18 years old * No signed informed consent form * Patients who haven't her social security insurance and prisoners are not eligible. * No evaluation of the axillary area. * Breast cancer in men

Design outcomes

Primary

MeasureTime frameDescription
Number of the days spent at the hospital post-surgery between the three groupsDay 0, 1, 8 and every 3 months for 2 years after surgeryThe aim of the study is to compare the recovering period hospitalisation and the different side effects (pain, anxiety, fatigue and consumption of pain killers ) during the post opérative period ( day 0, 1, 8- and at each follow up visit) between a group of patients with conventional sedation, a group using hypnosis as sedation during the surgery and a third group using hypnosis as a relaxation method and preparation but enjoying a classic sedation for their surgery
Comparaison of inflammatory parameters measured on day 0,1,8: CRP ( c reactive protein) and NLR ( neutrophils to lymphocyte ratio)Day 0, 1, 8Blood test performed

Secondary

MeasureTime frameDescription
Substudy evaluation of salivary immunoglobulins and endocannabinoids among 50 patients (25 under general anesthesia and 25 under hypnosis sedationSimples collected on Day 0, 1 and 8 for endocannabinoids and salivary simples collected on Day 0 and 8Blood and salivary simples to observe if hypnosis modifies salivary parameters and endocannabinoids system

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026